Dr. Holman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
17837 First Avenue South
Suite 6
Normandy Park, WA 98148Phone+1 206-412-5347- Is this information wrong?
Summary
- Stress kills. Immuno-autonomics activates immune function to drive autoimmune diseases to excess. I founded Inmedix to stratify and address adverse autonomic nervous system (ANS) profile with next-generation heart rate variability (HRV). Contact me or visit www.inmedix.com if you want to know more. Thanks.
Education & Training
- University of WashingtonFellowship, Rheumatology, 1990 - 1992
- HCA HealthONEResidency, Internal Medicine, 1987 - 1990
- University of Missouri-Columbia School of MedicineClass of 1987
- Bowdoin CollegeAB, Chemistry, Magna Cum Laude, 1977 - 1981
- Thacher Schooldiploma, 1973 - 1977
Certifications & Licensure
- WA State Medical License 1990 - 2025
Awards, Honors, & Recognition
- President Northwest Rheumatism Society, 2005
- Fellow (FACR) American College of Rheumatology
Publications & Presentations
PubMed
- Considering Immuno-autonomics in Stratifying Successful Treatment of Rheumatoid Arthritis with Tumor Necrosis Factor Inhibition: Comment on Cohen et al. Rheumatol Ther...Andrew J. Holman, Edward C. Keystone, Ernest Choy, Daniel E. Furst, Peter C. Taylor, Norman Gaylis> ;Rheumatology and Therapy. 2021 Nov 10
- 3 citationsHeart rate variability analysis in rheumatology: past, present… and future?Manuel Martínez-Lavín, Andrew J Holman> ;Clinical and Experimental Rheumatology. 2021 Aug 31
- Immuno-autonomics as a Complement to Precision Medicine Guiding Treatment of Patients with Rheumatoid Arthritis: Comment on the Article by Tao et alAndrew J. Holman> ;Arthritis & Rheumatology. 2021 May 13
- Join now to see all
Press Mentions
- Inmedix Raises $31,470 to Support Kids with Arthritis at Seattle Children’s HospitalSeptember 15th, 2021
- Inmedix, a Boutique Biotech Company, Is Now Working on Commercializing Its Second Major Patent. The First Patent Was Acquired by a Large Pharmaceutical Company at an Historic ValuationJuly 18th, 2019
- Inmedix CEO to Co-Chair Immuno-Autonomics Study Group at 2018 Annual Meeting of the American College of RheumatologyOctober 20th, 2018
- Join now to see all
Professional Memberships
- Fellow
External Links
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: